| 产品名称 | MK 0822 - Odanacatib |
| 产品货号 | Axon 1771 CAS [603139-19-1] MF C25H27F4N3O3SMW 525.56 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description Potent and selective inhibitor of cathepsin K (CTSK or Cat K) References Certificates Categories Extra info CL Le Gall et al. Cathepsin K inhibitors as treatment of bone metastasis. Curr. Opin. Support. Palliat. Care. 2008, 2(3), 218. JY Gauthier et al. The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg. Med. Chem. Lett. 2008, 18(3), 923–928. EM Lewiecki. Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling. IDrugs. 2009, 12(12), 799-809. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Miscellaneous Cathepsin-K EC 3.4.22.8 Inhibitor of cathepsin K Chemical name (S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)biphenyl-4-yl)ethylamino)pentanamide Parent CAS No. [603139-19-1] Order Size Unit Price Stock 2 mg €80.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
MK 0822 - OdanacatibAxon 1771 CAS [603139-19-1] MF C25H27F4N3O3S
Description
Potent and selective inhibitor of cathepsin K (CTSK or Cat K)
Inhibitor of cathepsin K
Chemical name(S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)biphenyl-4-yl)ethylamino)pentanamide Parent CAS No.[603139-19-1] |
| 产品资料 |
